New Drug Approvals Archive - January 2005
Get news by email or subscribe to our news feeds.
January 2005
| January 7 |
Abraxane (paclitaxel protein-bound) for Injectable Suspension Date of Approval: January 7, 2005
Company: American Pharmaceutical Partners, Inc. / American Bioscience, Inc.
Treatment for: Breast Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer
Abraxane (paclitaxel protein-bound) is an albumin-bound form of the antineoplastic agent paclitaxel indicated for the treatment of breast cancer, non-small cell lung cancer, and pancreatic cancer. Abraxane (paclitaxel protein-bound) FDA Approval History |
| January 12 |
ThyroShield (potassium iodide) Oral Solution Date of Approval: January 12, 2005
Company: Fleming & Company
Treatment for: Radiation Emergency
ThyroShield (potassium iodide) is used to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine. ThyroShield (potassium iodide) FDA Approval History |
| January 14 |
Menactra (meningococcal conjugate vaccine) Date of Approval: January 14, 2005
Company: Sanofi Pasteur
Treatment for: Meningococcal Meningitis Prophylaxis
Menactra (meningococcal conjugate vaccine) is a quadrivalent conjugate vaccine indicated for the prevention of meningococcal disease. Menactra (meningococcal conjugate vaccine) FDA Approval History |
| January 19 |
Niravam (alprazolam) Orally Disintegrating Tablets Date of Approval: January 19, 2005
Company: Schwarz Pharma AG
Treatment for: Anxiety, Panic Disorder
Niravam (alprazolam) is an orally disintegrating benzodiazepine indicated for the short-term relief of anxiety and panic attacks. Niravam (alprazolam) FDA Approval History |
| January 31 |
New Formulation Approved: January 31, 2005
|
| January 31 |
Nascobal (cyanocobalamin)
New Formulation Approved: January 31, 2005
Nascobal (cyanocobalamin) FDA Approval History |
| April 25 |
Menactra (meningococcal conjugate vaccine)
Patient Population Altered: April 22, 2011
Menactra (meningococcal conjugate vaccine) FDA Approval History |
| October 12 |
Abraxane (paclitaxel protein-bound)
New Indication Approved: October 11, 2012
Abraxane (paclitaxel protein-bound) FDA Approval History |
| September 6 |
Abraxane (paclitaxel protein-bound)
New Indication Approved: September 6, 2013
Abraxane (paclitaxel protein-bound) FDA Approval History |
New Drug Approvals Archive
2016
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2015
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2014
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2013
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2012
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2011
January,
February,
March,
April,
May,
June,
July,
August,
October,
November,
December2010
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2009
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2008
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2007
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2006
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2005
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2004
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2003
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December
